Third Wave Files to Raise up to $100M in Potential Stock Offerings

Feb 13, 2008

NEW YORK (GenomeWeb News) – Third Wave Technologies said yesterday that it has field a shelf registration with the US Securities and Exchange Commission allowing it to sell up to $100 million in securities.

The molecular diagnostics company said it may sell an undetermined number of debt securities or common stock, which includes the rights to purchase preferred stock, and that all of these may be issued by exercising warrants.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Not a Unique Challenge Anymore

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Case Goes On

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

The Very Old, Very Young, and Very Talented

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

This Week in PLOS

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Main menu